Leveraging AI to Close Care Gaps & Transform Patient Journeys: A Focus on HPP

Pangaea Data enters AI collaboration with Alexion to help improve detection of HPP in adults

Pangaea Data Secures Strategic Investment from Topcon Healthcare to Close Care Gaps in Eye Care

From Thin Ice to Solid Ground: How AI is Changing Clinical Practice for the Better

GO BACK

Leveraging AI to Close Care Gaps & Transform Patient Journeys: A Focus on HPP

This blog discusses the complexities of diagnosing rare diseases, like HPP, and the role AI can have to close care gaps and improve outcomes.

Delayed diagnoses and gaps in care continue to challenge healthcare, especially in rare diseases like Hypophosphatasia (HPP). This blog delves into the complexities of the patient journey for HPP, uncovering the barriers clinicians face in delivering timely and accurate diagnoses. Discover how AI platforms, like Pangaea Data’s, are revolutionizing care by closing care gaps to help such patients receive timely diagnosis and clinical intervention.

Request Blog

Authors

David B. Everman, MD
Clinical Scientist,
Pangaea Data
Vibhor Gupta, PhD
Founder & CEO,
Pangaea Data
David Rhew, MD
Global Chief Medical Officer,
Microsoft